- Home
- IART vs IMTX Comparison
IART vs IMTX Comparison
Compare IART & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IART | IMTX |
|---|---|---|
| Founded | 1989 | N/A |
| Country | United States | Germany |
| Employees | N/A | 407 |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | IART | IMTX |
|---|---|---|
| Price | $19.79 | $9.08 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | $14.33 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 900.7K | 325.4K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.39 | N/A |
| Revenue Next Year | $3.40 | $25.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.70 | $5.05 |
| 52 Week High | $20.26 | $12.41 |
Technical Indicators
Market Signals| Indicator | IART | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 63.53 | 40.53 |
| Support Level | $10.61 | $8.99 |
| Resistance Level | $20.26 | $10.67 |
| Average True Range (ATR) | 0.85 | 0.46 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 85.23 | 5.04 |
Price Performance
Historical ComparisonAbout IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.